Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $94.17 +1.15%
Revenue Growth %: +5.3%
Financial Fact:
Cash dividends declared per common share: 0.31
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.3%
Financial Fact:
Cash dividends declared per common share: 0.31
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.23 billion.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
